Abstract
In early June the annual meeting of the American Society of Clinical Oncology (ASCO) took place. Several new hypotheses, therapy approaches and clinical studies were presented and intensively discussed. Some new developments in treatment of non-small cell lung cancer will be briefly discussed in this article.
© Georg Thieme Verlag KG Stuttgart · New York.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Cancer Vaccines / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / diagnosis*
-
Carcinoma, Non-Small-Cell Lung / therapy*
-
Erlotinib Hydrochloride
-
Humans
-
Lung Neoplasms / diagnosis*
-
Lung Neoplasms / therapy*
-
Molecular Imaging / methods
-
Quinazolines / therapeutic use*
Substances
-
Antineoplastic Agents
-
Cancer Vaccines
-
Quinazolines
-
Erlotinib Hydrochloride